MedTrace Logo

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

NCT03788369 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2026-04-15

No results posted yet for this study

Summary

This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.

Conditions

  • Percutaneous Coronary Revascularization
  • Coronary Stenosis
  • Coronary Artery Disease Progression
  • Coronary Artery Bypass Grafting

Interventions

PROCEDURE

Hybrid Coronary Revascularization

Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels.

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Seung-Jung Park

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-05
Primary Completion
2026-04-13
Completion
2026-04-13

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03788369 on ClinicalTrials.gov